¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"thyroid activity, method for"¿¡ ´ëÇÑ °æºÏ´ëÇб³ Ä¡°ú´ëÇÐ ±¸°³»°úÇб³½Ç »çÀü ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
¼³¸í
helper cell activity
ÇïÆÛ ¼¼Æ÷ Ȱ¼º
impaired occupational activity
»çȸÀû ¹× Á÷¾÷Àû Ȱµ¿ Àå¾Ö, Á÷¾÷Àû Ȱµ¿ Àå¾Ö
impaired social activity
»çȸÀû Ȱµ¿ Àå¾Ö
intrinsic sympathomimetic activity
³»Àμº ±³°¨½Å°æ À¯»ç ÀÛ¿ë
lip activity
ÀÔ¼ú ¿îµ¿, ÀÔ¼ú Ȱµ¿·Â
maintained activity
Ȱ¼º À¯Áö
mental activity
Á¤½Å Ȱµ¿
molar activity
¸ô Ȱ¼º
muscle activity
±Ù Ȱ¼º
muscular activity
±ÙÀ° Ȱµ¿, ±Ù Ȱ¼ºµµ
neuromuscular reflex activity
±Ù½Å°æ ¹Ý»ç Ȱµ¿
nociceptor activity
Ä§ÇØ ¼ö¿ëü Ȱ¼º, À¯ÇØ ¼ö¿ë±â Ȱ¼º
partial agonistic activity
ºÎºÐ È¿´É, ºÎºÐ È¿´ÉÀû Ȱ¼º, ºÎºÐ È¿ÇöÀû Ȱ¼º
persistent activity
Áö¼ÓÀûÀΠȰ¼º
phagocytic activity
½Ä¼¼Æ÷´É
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
¼³¸í
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½